These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2886996)

  • 21. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):539-44. PubMed ID: 1676847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemistry of the metabolism of MDMA to MDA.
    Fitzgerald RL; Blanke RV; Rosecrans JA; Glennon RA
    Life Sci; 1989; 45(4):295-301. PubMed ID: 2569654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus properties of MDA analogs.
    Glennon RA; Young R; Rosecrans JA; Anderson GM
    Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDMA produces stimulant-like conditioned locomotor activity.
    Gold LH; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):352-6. PubMed ID: 2574478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalization of serotonin and dopamine ligands to the discriminative stimulus effects of different doses of ±3,4-methylenedioxymethamphetamine.
    Webster JI; Harper DN; Schenk S
    Behav Pharmacol; 2017 Jun; 28(4):245-254. PubMed ID: 27922542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.
    Murnane KS; Murai N; Howell LL; Fantegrossi WE
    J Pharmacol Exp Ther; 2009 Nov; 331(2):717-23. PubMed ID: 19684254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists.
    Glennon RA; Higgs R; Young R; Issa H
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1099-106. PubMed ID: 1361990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats.
    Schechter MD
    Pharmacol Biochem Behav; 1998 Feb; 59(2):265-70. PubMed ID: 9476968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
    Zacny JP; Virus RM; Woolverton WL
    Pharmacol Biochem Behav; 1990 Mar; 35(3):637-42. PubMed ID: 1971112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S(+)- and R(-)N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine.
    Bondareva T; Wesołowska A; Dukat M; Lee M; Young R; Glennon RA
    Pharmacol Biochem Behav; 2005 Nov; 82(3):531-8. PubMed ID: 16337676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.
    Nader MA; Hoffmann SM; Barrett JE
    Psychopharmacology (Berl); 1989; 98(2):183-8. PubMed ID: 2569215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2020 Jun; 31(4):378-384. PubMed ID: 31895060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
    Rangisetty JB; Bondarev ML; Chang-Fong J; Young R; Glennon RA
    Pharmacol Biochem Behav; 2001; 69(1-2):261-7. PubMed ID: 11420094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys.
    Thompson DM; Winsauer PJ; Mastropaolo J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):401-5. PubMed ID: 2883665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA; Marek GJ; Vosmer G; Seiden LS
    Pharmacol Biochem Behav; 1989 Jul; 33(3):641-8. PubMed ID: 2573905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT; Nash JF; Meltzer HY
    Eur J Pharmacol; 1989 Apr; 163(1):157-61. PubMed ID: 2472965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine.
    Kueh D; Baker LE
    Psychopharmacology (Berl); 2007 Jan; 189(4):447-57. PubMed ID: 17019568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.